I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 29% ± 9% | |
| glutamatergic neuron | 3 studies | 26% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 29% ± 9% | |
| glutamatergic neuron | 3 studies | 26% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1129.52 | 1445 / 1445 | 100% | 19.69 | 183 / 183 |
| lung | 100% | 1436.54 | 578 / 578 | 100% | 19.39 | 1151 / 1155 |
| ovary | 100% | 1521.41 | 180 / 180 | 99% | 11.89 | 426 / 430 |
| breast | 100% | 1275.49 | 459 / 459 | 99% | 23.83 | 1107 / 1118 |
| prostate | 100% | 1287.41 | 245 / 245 | 99% | 23.74 | 496 / 502 |
| thymus | 100% | 1548.14 | 653 / 653 | 98% | 20.43 | 594 / 605 |
| brain | 99% | 746.90 | 2622 / 2642 | 99% | 12.54 | 696 / 705 |
| pancreas | 100% | 819.81 | 328 / 328 | 98% | 14.83 | 174 / 178 |
| kidney | 100% | 989.07 | 89 / 89 | 97% | 23.35 | 876 / 901 |
| adrenal gland | 100% | 1277.19 | 258 / 258 | 97% | 15.70 | 223 / 230 |
| stomach | 100% | 842.67 | 359 / 359 | 97% | 16.61 | 277 / 286 |
| uterus | 100% | 1333.96 | 170 / 170 | 97% | 14.46 | 443 / 459 |
| intestine | 100% | 1304.46 | 966 / 966 | 96% | 15.51 | 506 / 527 |
| liver | 100% | 1428.76 | 226 / 226 | 96% | 14.43 | 388 / 406 |
| bladder | 100% | 1064.10 | 21 / 21 | 94% | 12.30 | 472 / 504 |
| skin | 99% | 1200.51 | 1798 / 1809 | 90% | 16.15 | 427 / 472 |
| blood vessel | 100% | 1406.61 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.37 | 29 / 29 |
| muscle | 100% | 1085.00 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1131.99 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1418.17 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 1092.79 | 852 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 15.05 | 44 / 45 |
| peripheral blood | 78% | 794.49 | 720 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 73% | 10.28 | 58 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007030 | Biological process | Golgi organization |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0042834 | Molecular function | peptidoglycan binding |
| Gene name | LYSMD3 |
| Protein name | LysM and putative peptidoglycan-binding domain-containing protein 3 HCG37164, isoform CRA_c (LysM domain containing 3) |
| Synonyms | hCG_37164 |
| Description | FUNCTION: Essential for Golgi structural integrity. . FUNCTION: Essential for Golgi structural integrity. . |
| Accessions | ENST00000453259.2 Q7Z3D4 ENST00000315948.11 [Q7Z3D4-1] A8K613 ENST00000509384.5 [Q7Z3D4-2] G5E9N8 ENST00000500869.6 [Q7Z3D4-3] |
